2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) is a type of skin cancer that typically arises from the squamous cells found in the outer layer of the skin. While it's commonly linked to sun exposure, it can also develop on areas of the body not exposed to sunlight. Research in SCC focuses on understanding its molecular mechanisms and identifying effective treatments. Recent advancements include targeted therapies that aim to inhibit specific pathways involved in cancer growth, immunotherapies harnessing the body's immune system to fight cancer cells, and innovative surgical techniques for precise removal of tumors. Additionally, studies delve into risk factors such as genetic predispositions and environmental exposures to develop preventive strategies. Collaborative efforts between clinicians, researchers, and pharmaceutical companies drive progress in improving outcomes for SCC patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China